Efficacy and safety of drospirenone 2 mg/17β-estradiol 1 mg hormone therapy in Korean postmenopausal women

This regulatory post-marketing surveillance study aimed to evaluate the therapeutic efficacy and safety of drospirenone (DRSP) 2 mg/estradiol (E(2)) 1 mg tablet in Korean postmenopausal women. A total of 4,149 patients were enrolled and the study was conducted at 207 clinical research centers. The p...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Bo Ra, Park, Hye Na, Jung, Ji Back, Lee, Eun Sil, Kim, Jeong Sig, Choi, Gyu Yeon, Lee, Jeong Jae, Lee, Im Soon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology; Korean Urogynecologic Society 2017
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364105/
https://www.ncbi.nlm.nih.gov/pubmed/28344964
http://dx.doi.org/10.5468/ogs.2017.60.2.213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364105/
https://www.ncbi.nlm.nih.gov/pubmed/28344964
http://dx.doi.org/10.5468/ogs.2017.60.2.213

Ejemplares similares